Type II monocytes modulate T cell–mediated central nervous system autoimmune disease

Weber, Martin S, Prod'homme, Thomas, Youssef, Sawsan, Dunn, Shannon E, Rundle, Cynthia D, Lee, Linda, Patarroyo, Juan C, Stüve, Olaf +3 more·2007·Nature Medicine

Cited by (441)

Items 101–200 of 441

  1. Immunity and cognition: what do age-related dementia, HIV-dementia and ‘chemo-brain’ have in common?
    Kipnis, Jonathan, Derecki, Noel Christopher, Yang, Chunhui, Scrable, Heidi · 2008 · Trends in Immunology
  2. Glatiramer acetate reduces Th-17 inflammation and induces regulatory T-cells in the CNS of mice with relapsing–remitting or chronic EAE
    Rina Aharoni, Raya Eilam, Ariel D. Stock, Anya Vainshtein, Elias Shezen, Hilah Gal, Nir Friedman, Ruth Arnon · 2010 · Journal of Neuroimmunology
  3. Immune regulation of multiple sclerosis by transdermally applied myelin peptides
    Maciej Juryńczyk, Agata Walczak, Anna Jurewicz, Dorota Jesionek‐Kupnicka, Marian Szczepanik, Krzysztof W. Selmaj · 2010 · Annals of Neurology
  4. IL4I1 augments CNS remyelination and axonal protection by modulating T cell driven inflammation
    Konstantina Psachoulia, Kelly A. Chamberlain, Dongeun Heo, Stephanie E. Davis, Jeremiah D. Paskus, Sonia E. Nanescu, Jeffrey L. Dupree, Thomas A. Wynn, Jeffrey K. Huang · 2016 · Brain
  5. B-Cell Therapies in Multiple Sclerosis
    Joseph J. Sabatino, Scott S. Zamvil, Stephen L. Hauser · 2018 · Cold Spring Harbor Perspectives in Medicine
  6. FLASH radiation reprograms lipid metabolism and macrophage immunity and sensitizes medulloblastoma to CAR-T cell therapy
    Haiwei Ni, Zachary J. Reitman, Wei Zou, Md. Naushad Akhtar, Ritama Paul, Menggui Huang, Duo Zhang, Hao Zheng, Ruitao Zhang, Ruiying Ma et al. · 2025 · Nature Cancer
  7. Protective effect of exercise training against the progression of Alzheimer’s disease in 3xTg-AD mice
    Donghyun Kim, Jinkyung Cho, Hyun‐Sik Kang · 2019 · Behavioural Brain Research
  8. Immunomodulation neuroprotection and remyelination – The fundamental therapeutic effects of glatiramer acetate: A critical review
    Rina Aharoni · 2014 · Journal of Autoimmunity
  9. Kinetics of Proinflammatory Monocytes in a Model of Multiple Sclerosis and Its Perturbation by Laquinimod
    Manoj Kumar Mishra, Janet Wang, Cláudia Silva, Mathias Mack, Voon Wee Yong · 2012 · American Journal Of Pathology
  10. Myeloid cell plasticity in the evolution of central nervous system autoimmunity
    David A. Giles, Jesse M. Washnock-Schmid, Patrick C. Duncker, Somiah Dahlawi, Gerald D. Ponath, David Pitt, Benjamin M. Segal · 2017 · Annals of Neurology
  11. Deciphering the Role of B Cells in Multiple Sclerosis—Towards Specific Targeting of Pathogenic Function
    Klaus Lehmann‐Horn, Silke Häusser‐Kinzel, Martin S. Weber · 2017 · International Journal of Molecular Sciences
  12. The good and the bad of neuroinflammation in multiple sclerosis
    Matthias Naegele, Roland Martinꝉ · 2014 · Handbook of clinical neurology
  13. Requirement for safety monitoring for approved multiple sclerosis therapies: an overview
    Paulus Stefan Rommer, Uwe Klaus Zettl, B. C. Kieseier, H-P Hartung, Til Menge, Elliot M. Frohman, Benjamin M. Greenberg, Bernhard Hemmer, Olaf Stüve · 2013 · Clinical & Experimental Immunology
  14. The Evolving Mechanisms of Action of Glatiramer Acetate
    Thomas Prod’homme, Scott S. Zamvil · 2018 · Cold Spring Harbor Perspectives in Medicine
  15. CAR-T Cell–Mediated B-Cell Depletion in Central Nervous System Autoimmunity
    Sasha Gupta, Milos Simic, Sharon A. Sagan, Chanelle Shepherd, Jason Duecker, Raymond A. Sobel, Ravi Dandekar, Gregory F. Wu, Wesley C. H. Wu, John E. Pak et al. · 2023 · Neurology Neuroimmunology & Neuroinflammation
  16. From phagocyte diversity and activation to probiotics: Back to Metchnikoff
    Alberto Mantovani · 2008 · European Journal of Immunology
  17. Microglial Activation Milieu Controls Regulatory T Cell Responses
    Friederike Ebner, Christine Brandt, Peggy Thiele, Daniel Richter, Ulrike Schliesser, Volker Siffrin, Jutta Schueler, Tobias Stubbe, Agnes Ellinghaus, Christian Meisel et al. · 2013 · The Journal of Immunology
  18. Distinct pathological patterns in relapsing–remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate
    Rina Aharoni, Anya Vainshtein, Ariel D. Stock, Raya Eilam, Renana From, Vera Shinder, Ruth Arnon · 2011 · Journal of Autoimmunity
  19. Communication between pathogenic T cells and myeloid cells in neuroinflammatory disease
    Laura Codarri Deak, Melanie Greter, Burkhard Becher · 2012 · Trends in Immunology
  20. MicroRNA-181 Variants Regulate T Cell Phenotype in the Context of Autoimmune Neuroinflammation
    Samira Ghorbani, Farideh Talebi, Wing Fuk Chan, Farimah Masoumi, Mohammed Vojgani, Christopher Power, Farshid Noorbakhsh · 2017 · Frontiers in Immunology
  21. Prioritizing disease and trait causal variants at the TNFAIP3 locus using functional and genomic features
    John P. Ray, Carl G. de Boer, Charles P. Fulco, C. Lareau, M. Kanai, J. Ulirsch, R. Tewhey, Leif S. Ludwig, S. Reilly, Drew T. Bergman et al. · 2020 · Nature Communications
  22. Serotonin Modulation of Macrophage Polarization: Inflammation and Beyond
    Mateo de las Casas-Engel, Angel Luis Corbí · 2014 · Advances in experimental medicine and biology
  23. Plasticity of Ly-6Chi Myeloid Cells in T Cell Regulation
    Bing Zhu, Jennifer K. Kennedy, Yue Wang, Carolina Sandoval-Garcia, Li Cao, Sheng Xiao, Chuan Wu, Wassim Elyaman, Samia Joseph Khoury · 2011 · The Journal of Immunology
  24. Selective Activation of Cannabinoid Receptor 2 in Leukocytes Suppresses Their Engagement of the Brain Endothelium and Protects the Blood-Brain Barrier
    Slava Rom, Viviana Zuluaga‐Ramirez, Holly Dykstra, Nancy Lee Reichenbach, Pál Pacher, Yuri Persidsky · 2013 · American Journal Of Pathology
  25. Treatment with the Antipsychotic Agent, Risperidone, Reduces Disease Severity in Experimental Autoimmune Encephalomyelitis
    David O'Sullivan, Laura Green, Sarrabeth Stone, Pirooz Zareie, Marie Kharkrang, Dahna M. Fong, Bronwen J. Connor, Anne Camille La Flamme · 2014 · PLoS ONE
  26. Mechanism of experimental autoimmune encephalomyelitis in Lewis rats: recent insights from macrophages
    Taekyun Shin, Meejung Ahn, Yoh Matsumoto · 2012 · Anatomy & Cell Biology
  27. Recent insights into the mechanism of action of glatiramer acetate
    Mrinalini Kala, Augusto A. Miravalle, Timothy L. Vollmer · 2011 · Journal of Neuroimmunology
  28. Coxsackievirus infection as an environmental factor in the etiology of type 1 diabetes
    Martin J. Richer, Marc Steven Horwitz · 2009 · Autoimmunity Reviews
  29. Influence of low oxygen tensions on macrophage polarization
    María Marta Escribese, Mateo Casas, Angel Luis Corbí · 2012 · Immunobiology
  30. Glatiramer Acetate Modulates TNF-α and IL-10 Secretion in Microglia and Promotes Their Phagocytic Activity
    Refik Pul, Darius Moharregh-Khiabani, Jelena Škuljec, Thomas Skripuletz, Niklas Garde, Elke Verena Voß, Martin Stangel · 2010 · Journal of Neuroimmune Pharmacology
  31. Structural Insight into the Function of Myelin Basic Protein as a Ligand for Integrin αMβ2
    Romualdas Stapulionis, Cristiano L. P. Oliveira, Mikkel Carstensen Gjelstrup, Jan Skov Pedersen, Marianne Hokland, Søren Vrønning Hoffmann, Knud Poulsen, Christian Borch Jacobsen, Thomas Vorup‐Jensen · 2008 · The Journal of Immunology
  32. Type II‐activated macrophages suppress the development of experimental autoimmune encephalomyelitis
    Joanna Tierney, Marie Kharkrang, Anne Camille La Flamme · 2008 · Immunology and Cell Biology
  33. Targeting dendritic cells to treat multiple sclerosis
    Manuel Comabella, Xavier Montalbán, Christian Münz, Jan D. Lünemann · 2010 · Nature Reviews Neurology
  34. Biomaterials Strategies for Generating Therapeutic Immune Responses
    Sean H. Kelly, Lucas S Shores, Nicole L. Votaw, J. Collier · 2017 · Advanced Drug Delivery Reviews
  35. Disease-Modifying Agents for Multiple Sclerosis
    Til Menge, Martin S. Weber, Bernhard Hemmer, Bernd C. Kieseier, H.‐Christian von Büdingen, Clemens Warnke, Scott S. Zamvil, Aaron Lee Boster, Omar Khan, Hans Peter Hartung et al. · 2008 · Drugs
  36. Early Life Exposure to Lipopolysaccharide Suppresses Experimental Autoimmune Encephalomyelitis by Promoting Tolerogenic Dendritic Cells and Regulatory T Cells
    Kristofor K. Ellestad, Shigeki Tsutsui, Farshid Noorbakhsh, Kenneth G. Warren, Voon Wee Yong, Quentin J. Pittman, Christopher Power · 2009 · The Journal of Immunology
  37. Remyelination Therapy for Multiple Sclerosis
    Michael B. Keough, Voon Wee Yong · 2012 · Neurotherapeutics
  38. Immune regulation of multiple sclerosis by CD8+ T cells
    Sushmita Sinha, Farah R. Itani, Nitin J. Karandikar · 2014 · Immunologic Research
  39. Immune mechanisms and shared immune targets in neurodegenerative diseases
    Howard L. Weiner · 2024 · Nature Reviews Neurology
  40. Laquinimod Delays and Suppresses Nephritis in Lupus‐Prone Mice and Affects Both Myeloid and Lymphoid Immune Cells
    Elaine Vicente Lourenço, Maida Wong, Bevra Hannahs Hahn, Miguel Palma-Diaz, Brian J. Skaggs · 2013 · Arthritis & Rheumatology
  41. Protective autoimmunity in the nervous system
    Jerome J. Graber, Suhayl S. Dhib-Jalbut · 2008 · Pharmacology & Therapeutics
  42. Downregulation of IL-17 and IL-6 in the central nervous system by glatiramer acetate in experimental autoimmune encephalomyelitis
    Sakhina Begum-Haque, Alok Sharma, Isaac R. Kasper, David Foureau, Daniel W. Mielcarz, Azizul Haque, Lloyd H. Kasper · 2008 · Journal of Neuroimmunology
  43. Apoptosis induced by parasitic diseases
    Anne‐Lise Bienvenu, Elena González‐Rey, Stéphane Picot · 2010 · Parasites & Vectors
  44. Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target
    Insha Zahoor, Hamid Suhail, Indrani Datta, Mohammad Ejaz Ahmed, Laila Poisson, Jeffrey Waters, Faraz Rashid, Bin Rui, Jaspreet Singh, Mirela Cerghet et al. · 2022 · Proceedings of the National Academy of Sciences
  45. A review on nanotechnology based innovations in diagnosis and treatment of multiple sclerosis
    Smriti Ojha, Babita Kumar · 2017 · Journal of Cellular Immunotherapy
  46. Treatment of multiple sclerosis: current concepts and future perspectives
    Dorothea Buck, Bernhard Hemmer · 2011 · Journal of Neurology
  47. Shedded neuronal ICAM-5 suppresses T-cell activation
    Li Tian, Jani Lappalainen, Matti Autero, Satu M. Hänninen, Heikki Rauvala, Carl Gustav Gahmberg · 2008 · Blood
  48. Type II-Activated Murine Macrophages Produce IL-4
    Anne Camille La Flamme, Marie Kharkrang, Sarrabeth Stone, Sara Mirmoeini, Delgertsetseg Chuluundorj, Ryan L. Kyle · 2012 · PLoS ONE
  49. Genetic susceptibility to systemic lupus erythematosus protects against cerebral malaria in mice
    Michael Waisberg, Tatyana Tarasenko, Brandi K. Vickers, Bethany L. Scott, Lisa C. Willcocks, Alvaro Molina-Cruz, Matthew A. Pierce, Chiung‐Yu Huang, Fernando J Torres-Velez, Kenneth G. C. Smith et al. · 2010 · Proceedings of the National Academy of Sciences
  50. Differential Macrophage Polarization from Pneumocystis in Immunocompetent and Immunosuppressed Hosts: Potential Adjunctive Therapy during Pneumonia
    Vijayalakshmi Nandakumar, Deanne M. Hebrink, Paige E. Jenson, Theodore J. Kottom, ANDREW HAR LIMPER · 2016 · Infection and Immunity
  51. Bone marrow-derived alternatively activated macrophages reduce colitis without promoting fibrosis: participation of IL-10
    Gabriella Leung, Arthur Wang, Maria Fernando, Van Phan, Derek Mark McKay · 2013 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  52. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ
    Stephanie Hucke, Juliane Floßdorf, Berit Grützke, Ildikò Rita Dunay, Kathrin Frenzel, Johannes Jungverdorben, Bettina Linnartz‐Gerlach, Matthias Mack, Michael Peitz, Oliver Brüstle et al. · 2012 · Brain
  53. Phosphorus-Based Dendrimer ABP Treats Neuroinflammation by Promoting IL-10-Producing CD4+ T Cells
    Myriam Hayder, Marjorie Varilh, Cédric‐Olivier Turrin, Abdelhadi Saoudi, Anne‐Marie Caminade, Rémy Poupot, Roland Liblau · 2015 · Biomacromolecules
  54. Bryostatin-1 alleviates experimental multiple sclerosis
    Michael D. Kornberg, Matthew D. Smith, Hasti Atashi Shirazi, Peter A. Calabresi, Solomon H. Snyder, Paul M. Kim · 2018 · Proceedings of the National Academy of Sciences
  55. Amino acid copolymer-specific IL-10-secreting regulatory T cells that ameliorate autoimmune diseases in mice
    Joel N. H. Stern, Derin B. Keskin, Hong Zhang, HuiJuan Lv, Zenichiro Kato, Jack L. Strominger · 2008 · Proceedings of the National Academy of Sciences
  56. Partial MHC class II constructs inhibit MIF / CD 74 binding and downstream effects
    Gil Benedek, Roberto Meza‐Romero, Shayne F. Andrew, Lin Leng, Gregory G. Burrows, DENNIS N. BOURDETTE, Halina Offner, Richard Bucala, Arthur A. Vandenbark · 2013 · European Journal of Immunology
  57. A strocyte disruption of neurovascular communication is linked to cortical damage in an animal model of multiple sclerosis
    Raya Eilam, Menahem Segal, Rafael Malach, Michael Sela, Ruth Arnon, Rina Aharoni · 2018 · Glia
  58. Dwellers and Trespassers: Mononuclear Phagocytes at the Borders of the Central Nervous System
    Daniela C. Ivan, Sabrina Walthert, Kristina Berve, Jasmin Steudler, Giuseppe Locatelli · 2021 · Frontiers in Immunology
  59. Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis
    Sakhina Begum-Haque, Alok K Sharma, Marc Christy, Tim Lentini, Javier Ochoa‐Repáraz, Islam Fayed, Daniel W. Mielcarz, Azizul Haque, Lloyd H. Kasper · 2010 · Journal of Neuroimmunology
  60. Glatiramer acetate for treatment of relapsing–remitting multiple sclerosis
    Kenneth P. Johnson · 2012 · Expert Review of Neurotherapeutics
  61. Progranulin Is Positively Associated with Intervertebral Disc Degeneration by Interaction with IL-10 and IL-17 Through TNF Pathways
    Shaoyi Wang, Jianlu Wei, Yu‐Chen Fan, Hong Ding, Huichao Tian, Xiaocong Zhou, Lei Cheng · 2018 · Inflammation
  62. IL-13-Mediated Gender Difference in Susceptibility to Autoimmune Encephalomyelitis
    Sushmita Sinha, Laurie J. Kaler, Thomas M Proctor, Cory Teuscher, Arthur A. Vandenbark, Halina Offner · 2008 · The Journal of Immunology
  63. Glucocorticoid Therapy of Multiple Sclerosis Patients Induces Anti-inflammatory Polarization and Increased Chemotaxis of Monocytes
    Henrike Josephine Fischer, Tobias Lukas Klaus Finck, Hannah Pellkofer, Holger Michael Reichardt, Fred Lühder · 2019 · Frontiers in Immunology
  64. Rett syndrome and other autism spectrum disorders—brain diseases of immune malfunction?
    Noel Christopher Derecki, Eve Privman, Jonathan Kipnis · 2010 · Molecular Psychiatry
  65. Augmentation of regulatory B cell activity in experimental allergic encephalomyelitis by glatiramer acetate
    Sakhina Begum-Haque, Marc Christy, Javier Ochoa‐Repáraz, Elizabeth C. Nowak, Daniel W. Mielcarz, Azizul Haque, Lloyd H. Kasper · 2010 · Journal of Neuroimmunology
  66. Adoptive transfer of Trichinella spiralis-activated macrophages can ameliorate both Th1- and Th2-activated inflammation in murine models
    Shin Ae Kang, Mi-Kyung Park, Sang Kyun Park, Jun Ho Choi, Da In Lee, So Myong Song, Hak Sun Yu · 2019 · Scientific Reports
  67. A silent agonist of α7 nicotinic acetylcholine receptors modulates inflammation ex vivo and attenuates EAE
    Jean‐Rémi Godin, Patrick Roy, Marta Quadri, Deniz Bağdaş, Wisam B. Toma, Ramya Narendrula-Kotha, Osama A. Kishta, Mohamad Imad Damaj, Nicole A. Horenstein, Roger L. Papke et al. · 2019 · Brain Behavior and Immunity
  68. Glatiramer Acetate Treatment of Multiple Sclerosis: An Immunological Perspective
    Michael K. Racke, Amy E. Lovett‐Racke · 2011 · The Journal of Immunology
  69. B Cell-Directed Therapeutics in Multiple Sclerosis: Rationale and Clinical Evidence
    Silke Häusser‐Kinzel, Martin S. Weber · 2016 · CNS Drugs
  70. Ang-(1–7)/MasR axis promotes functional recovery after spinal cord injury by regulating microglia/macrophage polarization
    Guangjin Gu, Bin Zhu, Jie Ren, Xiaomeng Song, Baoyou Fan, Han Ding, Jun Shang, Heng Wu, Junjin Li, Hongda Wang et al. · 2023 · Cell & Bioscience
  71. Alternatively Activated Macrophages in Spinal Cord Injury and Remission: Another Mechanism for Repair?
    Taekyun Shin, Meejung Ahn, Changjong Moon, Seungjoon Kim, Ki‐Bum Sim · 2013 · Molecular Neurobiology
  72. Role and therapeutic value of dendritic cells in central nervous system autoimmunity
    Francisco Javier Quintana, Ada Yeste, Iván Darío Mascanfroni · 2014 · Cell Death and Differentiation
  73. Glatiramer Acetate Increases Phagocytic Activity of Human Monocytes In Vitro and in Multiple Sclerosis Patients
    Refik Pul, Franco Morbiducci, Jelena Škuljec, Thomas Skripuletz, Vikramjeet Singh, Ute Diederichs, Niklas Garde, Elke Verena Voß, Corinna Trebst, Martin Stangel · 2012 · PLoS ONE
  74. Dendritic cells in central nervous system autoimmunity
    Christopher Sie, Thomas Korn · 2016 · Seminars in Immunopathology
  75. Diversity of immune cell types in multiple sclerosis and its animal model: Pathological and therapeutic implications
    Yun Cheng, Li Sun, Zhongxiang Xie, Xueli Fan, Qingqing Cao, Jinming Han, Jie Zhu, Tao Jin · 2017 · Journal of Neuroscience Research
  76. Immunomodulation in multiple sclerosis: promises and pitfalls
    Calliope Athena Dendrou, Lars H. Fugger · 2017 · Current Opinion in Immunology
  77. CCR4 contributes to the pathogenesis of experimental autoimmune encephalomyelitis by regulating inflammatory macrophage function
    Eileen Forde, Rukiye-Nazan E. Dogan, William J. Karpus · 2011 · Journal of Neuroimmunology
  78. Interferon-β treatment for relapsing multiple sclerosis
    Bianca Weinstock‐Guttman, Murali Krishna Ramanathan, Robert Zivadinov · 2008 · Expert Opinion on Biological Therapy
  79. An immunosuppressive vascular niche drives macrophage polarization and immunotherapy resistance in glioblastoma
    Fan Yang, Md. Naushad Akhtar, Duo Zhang, Rakan D. El-Mayta, Junyoung Shin, Jay F. Dorsey, Lin Zhang, Xiaowei Xu, Wei Guo, Stephen Joseph Bagley et al. · 2024 · Science Advances
  80. Soluble Egg Antigen Activates M2 Macrophages via the STAT6 and PI3K Pathways, and Schistosoma Japonicum Alternatively Activates Macrophage Polarization to Improve the Survival Rate of Septic Mice
    Hao Tang, Yanbing Liang, Zhi‐bin Chen, Lin‐lin Du, Lijin Zeng, Jingguo Wu, Wen Yang, Huaping Liang, Zhong‐fu Ma · 2017 · Journal of Cellular Biochemistry
  81. Egr1 Expression Is Induced Following Glatiramer Acetate Immunotherapy in Rodent Models of Glaucoma and Alzheimer's Disease
    Sharon Bakalash, Michael D. Pham, Yosef Koronyo, Brenda C. Salumbides, Andrei A. Kramerov, Hillary Seidenberg, Dror Berel, Keith L. Black, Maya Koronyo‐Hamaoui · 2011 · Investigative Ophthalmology & Visual Science
  82. Comparing the Biological Impact of Glatiramer Acetate with the Biological Impact of a Generic
    Fadi Towfic, Jason M. Funt, Kevin D. Fowler, Shlomo Bakshi, Eran Blaugrund, Maxim N. Artyomov, Michael R. Hayden, David Ladkani, Rivka Schwartz, Benjamin J. Zeskind · 2014 · PLoS ONE
  83. What Do Effective Treatments for Multiple Sclerosis Tell Us about the Molecular Mechanisms Involved in Pathogenesis?
    Katherine A. Buzzard, Simon Broadley, Helmut Butzkueven · 2012 · International Journal of Molecular Sciences
  84. The GPIb-IX complex on platelets: insight into its novel physiological functions affecting immune surveillance, hepatic thrombopoietin generation, platelet clearance and its relevance for cancer development and metastasis
    Gerd Bendas, Martin Schlesinger · 2022 · Experimental Hematology and Oncology
  85. Laquinimod, an up-and-coming immunomodulatory agent for treatment of multiple sclerosis
    Michel Varrin‐Doyer, Scott S. Zamvil, Ulf Schulze‐Topphoff · 2014 · Experimental Neurology
  86. Regulatory T-Cells Protect From Type 1 Diabetes After Induction by Coxsackievirus Infection in the Context of Transforming Growth Factor-β
    Martin J. Richer, Nadine Straka, Dianne Fang, Iryna Shanina, Marc Steven Horwitz · 2008 · Diabetes
  87. Central Nervous System Fibrosis Is Associated with Fibrocyte-Like Infiltrates
    Amy L. Aldrich, Tammy Kielian · 2011 · American Journal Of Pathology
  88. Cell-Based Modulation of Autoimmune Responses in Multiple Sclerosis and Experimental Autoimmmune Encephalomyelitis: Therapeutic Implications
    Vasileios C. Mastorodemos, Μαριάννα Ιωάννου, Panayotis Verginis · 2014 · NeuroImmunoModulation
  89. Targeting and Specific Activation of Antigen‐Presenting Cells by Endogenous Antigen‐Loaded Nanoparticles Elicits Tumor‐Specific Immunity
    Haocai Chang, Zhengzhi Zou, Qiuhong Wang, Jie Li, Huan Jin, Qian-Xia Yin, Da Xing · 2019 · Advanced Science
  90. Fasudil mediates cell therapy of EAE by immunomodulating encephalomyelitic T cells and macrophages
    Chunyun Liu, Shang‐De Guo, Jie‐Zhong Yu, Yànhuá Lǐ, Hui Zhang, Ling Feng, Zhi Chai, Haijun Yuan, Wanfang Yang, Qianjin Feng et al. · 2014 · European Journal of Immunology
  91. FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosis
    Felix Luessi, Stefan H.P. Kraus, Bettina Trinschek, Steffen Lerch, Robert Ploen, Magdalena Paterka, Torsten Roberg, Laura Poisa-Beiro, Luisa Klotz, Heinz Wiendl et al. · 2015 · Multiple Sclerosis Journal
  92. Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing–remitting multiple sclerosis
    Aaron Lee Boster, Mary Pat Bartoszek, Colleen M. O’Connell, David Pitt, Michael K. Racke · 2011 · Therapeutic Advances in Neurological Disorders
  93. Opportunities for Translation from the Bench: Therapeutic Intervention of the JAK/STAT Pathway in Neuroinflammatory Diseases
    Yudong Liu, Sara A. Gibson, Etty N. Benveniste, Hongwei Qin · 2015 · Critical Reviews in Immunology
  94. Immunologic Aspects of Multiple Sclerosis
    Sridhar Boppana, Hui Huang, Kouichi Ito, Suhayl S. Dhib-Jalbut · 2011 · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine
  95. Multiple sclerosis: glatiramer acetate induces anti-inflammatory T cells in the cerebrospinal fluid
    Anne Lise Karlsgot Hestvik, Gjertrud Skorstad, David A. Price, Frode Vartdal, Trygve Holmøy · 2008 · Multiple Sclerosis Journal
  96. Radiation-Induced Liver Fibrosis Is Mitigated by Gene Therapy Inhibiting Transforming Growth Factor-β Signaling in the Rat
    Shisuo Du, Qiang Ming, Zhao‐Chong Zeng, Jian Zhou, Yun-Shan Tan, Zhengyu Zhang, Haiying Zeng, Zhongshan Liu · 2010 · International Journal of Radiation Oncology*Biology*Physics
  97. Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System
    Cecília Rajda, Zsófia Majláth, Dániel Pukoli, László Vécsei · 2015 · International Journal of Molecular Sciences
  98. CD8+ T Cells Are Required For Glatiramer Acetate Therapy in Autoimmune Demyelinating Disease
    Andrew F. Tyler, Jason P. Mendoza, Mihail Firan, Nitin J. Karandikar · 2013 · PLoS ONE
  99. Glatiramer acetate persists at the injection site and draining lymph nodes via electrostatically-induced aggregation
    Jimmy Y. Song, Nicholas R. Larson, Sharadvi Thati, Irma Torres‐Vazquez, Noraida Martínez-Rivera, Natalia Subelzú, Martin A. Leon, Eduardo Rosa‐Molinar, Christian Schöneich, Marcus Laird Forrest et al. · 2018 · Journal of Controlled Release
  100. The farnesoid-X-receptor in myeloid cells controls CNS autoimmunity in an IL-10-dependent fashion
    Stephanie Hucke, Martin V. B. Herold, Marie Liebmann, Nicole Freise, Maren Lindner, Ann-Katrin Fleck, Stefanie Zenker, Stephanie Thiebes, Juncal Fernández‐Orth, Dorothea Buck et al. · 2016 · Acta Neuropathologica